ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Multimodal approach to optimize biopsy decision-making for PI-RADS 3 lesions on multiparametric MRI

Esengur, Omer Tarik; Yilmaz, Enis C.; Ozyoruk, Kutsev B.; Chen, Alex; Lay, Nathan S.; Gelikman, David G.; Merino, Maria J.; Gurram, Sandeep; Wood, Bradford J.; Choyke, Peter L.; Harmon, Stephanie A.; Pinto, Peter A.; Turkbey, Baris*
CLINICAL IMAGING2025-1DOI: 10.1016/j.clinimag.2024.110363
2阅读
引用收藏
分享

摘要

Purpose: To develop and evaluate a multimodal approach including clinical parameters and biparametric MRIbased artificial intelligence (AI) model for determining the necessity of prostate biopsy in patients with PIRADS 3 lesions. Methods: This retrospective study included a prospectively recruited patient cohort with PI-RADS 3 lesions who underwent prostate MRI and MRI/US fusion-guided biopsy between April 2019 and February 2024 in a single institution. The study examined demographic data, PSA and PSA density (PSAD) levels, prostate volumes, prospective PI-RADS v2.1-compliant interpretations of a genitourinary radiologist, lesion characteristics, history of prior biopsies, and AI evaluations, focusing mainly on the detection of clinically significant prostate cancer (csPCa) (International Society of Urological Pathology grade group >2) on MRI/US fusion-guided biopsy. The AI model lesion segmentations were compared to manual segmentations and biopsy results. The statistical methods employed included Fisher's exact test and logistic regression. Results: The cohort was comprised of 248 patients with 312 PI-RADS 3 lesions in total (n = 268 non-csPCa, n = 44 csPCa). The AI model's negative predictive value (NPV) was 89.2 % for csPCa in all lesions. In patient-level analysis, the NPV was 91.2 % for patients with a highest PI-RADS score of 3. PSAD was a significant predictor of csPCa (odds ratio = 5.8, p = 0.038). Combining AI and PSAD, where AI correctly mapped a lesion or PSAD >0.15 ng/mL2, achieved higher sensitivity (77.8 %) while maintaining a high NPV (93.1 %). Conclusion: Combining AI and PSAD has the potential to enhance biopsy decision-making for PI-RADS 3 lesions by minimizing missed csPCa occurrences and reducing unnecessary biopsies.

学科与关键词

关键词
Prostate cancerPI-RADS 3 lesionsArtificial intelligencePSA densityMultiparametric MRIBiopsy decision-making
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
CLINICAL IMAGING
发表日期
2025-01
卷期
第 117 卷
页码
110363
DOI
10.1016/j.clinimag.2024.110363
语言
ENGLISH
成果收录
SCIE

作者

  • E

    Esengur, Omer Tarik (第一作者)

  • Y

    Yilmaz, Enis C.

查看全部 13 位作者收起作者
  • O

    Ozyoruk, Kutsev B.

  • C

    Chen, Alex

  • L

    Lay, Nathan S.

  • G

    Gelikman, David G.

  • M

    Merino, Maria J.

  • G

    Gurram, Sandeep

  • W

    Wood, Bradford J.

  • C

    Choyke, Peter L.

  • H

    Harmon, Stephanie A.

  • P

    Pinto, Peter A.

  • T

    Turkbey, Baris (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417